Training | 2022.06.23
Syros Pharmaceuticals Implements Genedata Profiler to Accelerate Therapeutic Development for Genomically Targeted Patient Populations
An emerging leader in the development of small molecule medicines controlling the expression of genes implements an innovative computational platform to digitalize its translational R&D workflows
(PRWeb June 23, 2022)
Read the full story at https://www.prweb.com/releases/syros_pharmaceuticals_implements_genedata_profiler_to_accelerate_therapeutic_development_for_genomically_targeted_patient_populations/prweb18751846.htm
For more information, please visit
https://www.prweb.com/releases/syros_pha[...]_populations/prweb18751846.htm
